Pornjarim Nilyanimit

763 total citations
45 papers, 400 citations indexed

About

Pornjarim Nilyanimit is a scholar working on Infectious Diseases, Epidemiology and Hepatology. According to data from OpenAlex, Pornjarim Nilyanimit has authored 45 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 18 papers in Epidemiology and 10 papers in Hepatology. Recurrent topics in Pornjarim Nilyanimit's work include SARS-CoV-2 and COVID-19 Research (17 papers), Hepatitis B Virus Studies (14 papers) and COVID-19 Clinical Research Studies (12 papers). Pornjarim Nilyanimit is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (17 papers), Hepatitis B Virus Studies (14 papers) and COVID-19 Clinical Research Studies (12 papers). Pornjarim Nilyanimit collaborates with scholars based in Thailand, United Kingdom and United States. Pornjarim Nilyanimit's co-authors include Yong Poovorawan, Nasamon Wanlapakorn, Jira Chansaenroj, Chompoonut Auphimai, Sitthichai Kanokudom, Ritthideach Yorsaeng, Preeyaporn Vichaiwattana, Nungruthai Suntronwong, Suvichada Assawakosri and Natthinee Sudhinaraset and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Pornjarim Nilyanimit

41 papers receiving 397 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pornjarim Nilyanimit Thailand 12 221 117 85 63 47 45 400
Hamilton Bennett United States 6 283 1.3× 54 0.5× 130 1.5× 61 1.0× 50 1.1× 6 391
Chompoonut Auphimai Thailand 14 312 1.4× 131 1.1× 40 0.5× 102 1.6× 64 1.4× 26 438
Vidisha Singh United States 12 198 0.9× 144 1.2× 65 0.8× 33 0.5× 14 0.3× 16 357
Deniz Cizmeci United States 13 258 1.2× 130 1.1× 79 0.9× 25 0.4× 20 0.4× 28 436
Debra Hauer United States 14 314 1.4× 341 2.9× 68 0.8× 43 0.7× 30 0.6× 18 627
Carolyn M. Boudreau United States 7 184 0.8× 154 1.3× 62 0.7× 49 0.8× 21 0.4× 10 457
Donchida Srimuan Thailand 11 296 1.3× 71 0.6× 26 0.3× 108 1.7× 57 1.2× 27 362
Audrey L. Butler United States 6 165 0.7× 60 0.5× 35 0.4× 52 0.8× 19 0.4× 7 343
Ria Lassaunière Denmark 12 265 1.2× 131 1.1× 58 0.7× 27 0.4× 55 1.2× 33 442
Gabriele Anichini Italy 11 300 1.4× 59 0.5× 58 0.7× 50 0.8× 41 0.9× 27 377

Countries citing papers authored by Pornjarim Nilyanimit

Since Specialization
Citations

This map shows the geographic impact of Pornjarim Nilyanimit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pornjarim Nilyanimit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pornjarim Nilyanimit more than expected).

Fields of papers citing papers by Pornjarim Nilyanimit

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pornjarim Nilyanimit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pornjarim Nilyanimit. The network helps show where Pornjarim Nilyanimit may publish in the future.

Co-authorship network of co-authors of Pornjarim Nilyanimit

This figure shows the co-authorship network connecting the top 25 collaborators of Pornjarim Nilyanimit. A scholar is included among the top collaborators of Pornjarim Nilyanimit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pornjarim Nilyanimit. Pornjarim Nilyanimit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Poovorawan, Yong, et al.. (2025). Microelimination of Hepatitis C in Thailand, Phetchabun Model: Progress, Challenges, and Future Directions. Journal of Clinical Medicine. 14(11). 3946–3946. 1 indexed citations
2.
Kanokudom, Sitthichai, Pornjarim Nilyanimit, Jiratchaya Puenpa, et al.. (2025). A comparative national survey on the gradual decline of hepatitis C virus prevalence in Thailand, 2004, 2014, and 2024. Scientific Reports. 15(1). 19794–19794.
3.
Kanokudom, Sitthichai, et al.. (2025). Glecaprevir/Pibrentasvir Versus Sofosbuvir/Velpatasvir for Hepatitis C Virus Genotype 6: A Systematic Review and Meta‐Analysis. Reviews in Medical Virology. 35(6). e70074–e70074.
4.
Suntronwong, Nungruthai, Sitthichai Kanokudom, Chompoonut Auphimai, et al.. (2024). Long-Term Dynamic Changes in Hybrid Immunity over Six Months after Inactivated and Adenoviral Vector Vaccination in Individuals with Previous SARS-CoV-2 Infection. Vaccines. 12(2). 180–180. 3 indexed citations
5.
Hegde, Shivanand, Kamil Khanipov, Emily A. Hornett, et al.. (2024). Interkingdom interactions shape the fungal microbiome of mosquitoes. SHILAP Revista de lepidopterología. 6(1). 11–11. 5 indexed citations
6.
Yorsaeng, Ritthideach, Nungruthai Suntronwong, Sitthichai Kanokudom, et al.. (2023). SARS-CoV-2 Antibody Dynamics after COVID-19 Vaccination and Infection: A Real-World Cross-Sectional Analysis. Vaccines. 11(7). 1184–1184. 8 indexed citations
7.
Sawaswong, Vorthon, Kritsada Khongnomnan, Kesmanee Praianantathavorn, et al.. (2023). Development of a simplified and cost-effective sample preparation method for genotyping of human papillomavirus by next-generation sequencing. Archives of Virology. 168(7). 185–185. 1 indexed citations
8.
Kanokudom, Sitthichai, Jira Chansaenroj, Nungruthai Suntronwong, et al.. (2023). The Fourth Dose of mRNA COVID-19 Vaccine Following 12 Different Three-Dose Regimens: Safety and Immunogenicity to Omicron BA.4/BA.5. Vaccines. 11(3). 570–570. 7 indexed citations
9.
Assawakosri, Suvichada, Sitthichai Kanokudom, Nungruthai Suntronwong, et al.. (2023). Immunogenicity and durability against Omicron BA.1, BA.2 and BA.4/5 variants at 3–4 months after a heterologous COVID-19 booster vaccine in healthy adults with a two-doses CoronaVac vaccination. Heliyon. 10(1). e23892–e23892. 5 indexed citations
10.
Nilyanimit, Pornjarim, Rujipat Wasitthankasem, Nawarat Posuwan, et al.. (2023). An amino acid substitution in HCV core antigen limits its use as a reliable measure of HCV infection compared with HCV RNA. PLoS ONE. 18(6). e0287694–e0287694. 6 indexed citations
11.
Chansaenroj, Jira, Preeyaporn Vichaiwattana, Donchida Srimuan, et al.. (2023). Dynamics of Cytokine, SARS-CoV-2-Specific IgG, and Neutralizing Antibody Levels in COVID-19 Patients Treated with Convalescent Plasma. SHILAP Revista de lepidopterología. 11(3). 112–112. 3 indexed citations
12.
Assawakosri, Suvichada, Sitthichai Kanokudom, Nungruthai Suntronwong, et al.. (2022). Neutralizing Activities Against the Omicron Variant After a Heterologous Booster in Healthy Adults Receiving Two Doses of CoronaVac Vaccination. The Journal of Infectious Diseases. 226(8). 1372–1381. 41 indexed citations
13.
Assawakosri, Suvichada, Sitthichai Kanokudom, Jira Chansaenroj, et al.. (2022). Persistence of immunity against Omicron BA.1 and BA.2 variants following homologous and heterologous COVID-19 booster vaccines in healthy adults after a two-dose AZD1222 vaccination. International Journal of Infectious Diseases. 122. 793–801. 13 indexed citations
14.
Kanokudom, Sitthichai, Suvichada Assawakosri, Nungruthai Suntronwong, et al.. (2022). Safety and Immunogenicity of the Third Booster Dose with Inactivated, Viral Vector, and mRNA COVID-19 Vaccines in Fully Immunized Healthy Adults with Inactivated Vaccine. Vaccines. 10(1). 86–86. 48 indexed citations
15.
Suntronwong, Nungruthai, Suvichada Assawakosri, Sitthichai Kanokudom, et al.. (2022). Strong Correlations between the Binding Antibodies against Wild-Type and Neutralizing Antibodies against Omicron BA.1 and BA.2 Variants of SARS-CoV-2 in Individuals Following Booster (Third-Dose) Vaccination. Diagnostics. 12(8). 1781–1781. 13 indexed citations
17.
Suntronwong, Nungruthai, Ritthideach Yorsaeng, Jiratchaya Puenpa, et al.. (2022). COVID-19 Breakthrough Infection after Inactivated Vaccine Induced Robust Antibody Responses and Cross-Neutralization of SARS-CoV-2 Variants, but Less Immunity against Omicron. Vaccines. 10(3). 391–391. 13 indexed citations
18.
Nilyanimit, Pornjarim, et al.. (2017). Comparison of human papillomavirus (HPV) detection in urine and cervical swab samples using the HPV GenoArray Diagnostic assay. PeerJ. 5. e3910–e3910. 20 indexed citations
20.
Nilyanimit, Pornjarim, Nasamon Wanlapakorn, Somchai Niruthisard, et al.. (2013). Detection of Human Papillomavirus in Male and Female Urine by Electrochemical DNA Chip and PCR Sequencing. Asian Pacific Journal of Cancer Prevention. 14(9). 5519–5525. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026